Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-951-8 | CAS number: 719-80-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Oral:
Rat LD50 male = 681mg/kg b.w., female = 316mg/kg b.w. (BASF 1982, acc. to OECD401)
Inhalation (Vapor):
Rat: LC0 >= saturated air (BASF 1982, inhalation risk test)
I.p.
Rat: LD50 male= 1002mg/kg b.w., female = 508mg/kg b.w. (BASF 1982)
Key value for chemical safety assessment
Additional information
In an acute oral toxicity study according to OECD401 (BASF AG 1982), 5 male and 5 female fasted Wistar rats per dose were given a single oral dose of 681, 464, 316, or 215mg/kg in 0.5% CMC in water by gavage. The animals were observerd for 14 days and necropsy was performed. All females of the two highest doses died within 1 or 2 days, 3 males of the highest dose, 2 females receiving 316mg/kg b.w. and 1 female of the lowest dose died within 1 day after application. The expected body weight gain was observed during the study. Signs of toxicity included dyspnoe, apathy, staggering gait, impaired general state in all groups, abnormal position, atony, tonic cramps, piloerection, exsiccosis , exophthalmus in some groups, and no corneal reflex, no pain reflex, anaesthesia-like state in females in the two mid dosages. Discoloration (whitish grey to clay colored) of liver and kidney were noted in the animals that were found dead. Marks on the peripheral lobuli of the liver in 2 surviving males receving 464mg/kg were diagnosed as lipophanerosis during histopathological examination. No further abnormalities were noted. Thus the oral LD50 value for this substance is 681mg/kg b.w. for males and 316 mg/kg b.w. for females, or 456mg/kg b.w. for males and females combined.
In an acute inhalation risk test (BASF 1982), young adult Wistar rats (3 males and 3 females) were exposed to a saturated substance/air mixture for 7h, that was generated by bubbling air through a 5cm column of the liquid substance. The concentration was calculated to be <0.04mg/l via weight loss of inserted substance. The animals were observed for 14 days. No signs of systemic toxicity were observed in the animals. No abnormalities were noted at necropsy of animals sacrificed at the end of the study.
In an acute toxicity study (BASF AG 1982), 5 male and 5 female fasted Wistar rats per dose were injected intraperitoneally with a single of 1210, 825, 562, or 383mg/kg in 0.5% CMC in water. The animals were observerd for 14 days and necropsy was performed. All females of the two highest doses, 4 females receiving 562mg/kg b.w., 4 males of the highest dose, and 1 male of the second highest dose died mostly within 1 or 2 days after application. The expected body weight gain was observed during the study. Signs of toxicity in the three highest dose groups were dyspnoe, apathy, aggressivness, abnormal position, staggering gait, atony, cramps, piloerection, exsiccosis, exophthalmus, salivation, bad general state, no corneal reflex, no pain reflex, and anaesthesia-like state. The lowest dose only showed piloerection in both sexes. Animals found dead showed intraabdominal deposits of test substance and frequently a slight aszites. No abnormalities were noted at necropsy of animals sacrificed at the end of the study. Thus the LD50 value after i.p. injection for this substance is 1002mg/kg b.w. for males and 508 mg/kg b.w. for females, or 713mg/kg b.w. for males and females combined.
Justification for classification or non-classification
Based on the results of the available studies, ethyl diphenylphosphinite has to be classified as hazardous after oral uptake and labelled with R22 according to 67/548/EEC and H302 (acute toxicity oral, category 4) according to CLP/EU-GHS requirements.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
